David Pernock Eagle Pharmaceuticals, Inc. (EGRX) insider trading activity

EGRX Quotes by TradingView

David Pernock is Pres & Chief Operating Officer of EAGLE PHARMACEUTICALS, INC.. Currently has a direct ownership of 54,625 shares of EGRX, which is worth approximately $28,405. The most recent transaction as insider was on Feb 02, 2021, when has been sold 9,700 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 54.6K
0% 3M change
0% 12M change
Total Value Held $28,405

David Pernock Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 02 2021
BUY
Grant, award, or other acquisition
-
9,700 Added 15.08%
54,625 Common Stock
Jan 23 2021
SELL
Payment of exercise price or tax liability
$90,248 $47.7 p/Share
1,892 Reduced 4.04%
44,925 Common Stock
Jan 07 2021
SELL
Payment of exercise price or tax liability
$46,179 $50.97 p/Share
906 Reduced 1.9%
46,817 Common Stock
Jan 05 2021
SELL
Payment of exercise price or tax liability
$104,442 $50.02 p/Share
2,088 Reduced 4.19%
47,723 Common Stock
DP

David Pernock

Pres & Chief Operating Officer
Woodcliff Lake, NJ

Track Institutional and Insider Activities on EGRX

Follow EAGLE PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EGRX shares.

Notify only if

Insider Trading

Get notified when an Eagle Pharmaceuticals, Inc. insider buys or sells EGRX shares.

Notify only if

News

Receive news related to EAGLE PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EGRX